Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:Switzerland
|
| gptkbp:focus |
oncology
antibacterial drugs antifungal drugs |
| gptkbp:founded |
2000
|
| gptkbp:founder |
gptkb:Martin_E._Marty
|
| gptkbp:headquarters_location |
Basel
|
| https://www.w3.org/2000/01/rdf-schema#label |
Basilea Pharmaceutica
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:notableProduct |
gptkb:Isavuconazole
Ceftobiprole |
| gptkbp:numberOfEmployees |
~200
|
| gptkbp:stockExchange |
gptkb:SIX_Swiss_Exchange
|
| gptkbp:stockSymbol |
BSLN
|
| gptkbp:website |
https://www.basilea.com/
|
| gptkbp:bfsParent |
gptkb:242138-07-4
|
| gptkbp:bfsLayer |
6
|